TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Atezolizumab plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: A Multicenter, Open-Label, Single-Arm Phase II Study.

Lili Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.